Detection and measurement of staphylococcal enterotoxin-like K (SEl-K) secretion by Staphylococcus aureus clinical isolates

Journal of Clinical Microbiology

Volumn 52, Issue 7, 2014, Pages 2536-2543

  Aguilar, Jorge L ^a   Varshney, Avanish K ^a   Wang, Xiaobo ^a   Stanford, Lindsay ^a   Scharff, Matthew ^a   Fries, Bettina C ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGENIC AGENT; STAPHYLOCOCCAL ENTEROTOXIN LIKE K; UNCLASSIFIED DRUG; ENTEROTOXIN;

ABSCESS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIUM DETECTION; BACTERIUM ISOLATE; BIOACCUMULATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE; GENETIC VARIABILITY; IMMUNOASSAY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; SEL K GENE; SEQUENCE ANALYSIS; STAPHYLOCOCCUS INFECTION; THIGH; AMINO ACID SEQUENCE; ANIMAL; BAGG ALBINO MOUSE; BLOOD; DISEASE MODEL; DNA SEQUENCE; GENETICS; GENOTYPE; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; MOLECULAR GENETICS; PROCEDURES; SECRETION (PROCESS); SEQUENCE HOMOLOGY; STAPHYLOCOCCUS AUREUS;

AMINO ACID SEQUENCE; ANIMALS; DISEASE MODELS, ANIMAL; ENTEROTOXINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; HUMANS; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY, AMINO ACID; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 84903762653     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00387-14     Document Type: Article

References (46)

1. Lowy FD. 1998. Staphylococcus aureus infections. N. Engl. J. Med. 339: 520-532. http://dx.doi.org/10.1056/NEJM199808203390806.
2. Spaulding AR, Salgado-Pabon W, Kohler PL, Horswill AR, Leung DY, Schlievert PM. 2013. Staphylococcal and streptococcal superantigen exotoxins. Clin. Microbiol. Rev. 26:422-447. http://dx.doi.org/10.1128/CMR.00104-12.
3. Pinchuk IV, Beswick EJ, Reyes VE. 2010. Staphylococcal enterotoxins. Toxins 2:2177-2197. http://dx.doi.org/10.3390/toxins2082177.
4. Xu SX, McCormick JK. 2012. Staphylococcal superantigens in colonization and disease. Front. Cell. Infect. Microbiol. 2:52. http://dx.doi.org/10.3389/ fcimb.2012.00052.
5. Dinges MM, Orwin PM, Schlievert PM. 2000. Exotoxins of Staphylococcus aureus. Clin. Microbiol. Rev. 13:16-34, table of contents. http://dx.doi.org/10. 1128/CMR.13.1.16-34.2000.
6. Lina G, Bohach GA, Nair SP, Hiramatsu K, Jouvin-Marche E, Mariuzza R, International Nomenclature Committee for Staphylococcal Superantigens. 2004. Standard nomenclature for the superantigens expressed by Staphylococcus. J. Infect. Dis. 189:2334-2336. http://dx.doi.org/10.1086/420852. (Pubitemid 38757208)
7. Orwin PM, Leung DY, Donahue HL, Novick RP, Schlievert PM. 2001. Biochemical and biological properties of Staphylococcal enterotoxin K. Infect. Immun. 69:360-366. http://dx.doi.org/10.1128/IAI.69.1.360-366.2001. (Pubitemid 32038333)
8. Omoe K, Hu DL, Ono HK, Shimizu S, Takahashi-Omoe H, Nakane A, Uchiyama T, Shinagawa K, Imanishi K. 2013. Emetic potentials of newly identified staphylococcal enterotoxin-like toxins. Infect. Immun. 81: 3627-3631. http://dx.doi.org/10.1128/IAI.00550-13.
9. Günther S, Varma AK, Moza B, Kasper KJ, Wyatt AW, Zhu P, Rahman AK, Li Y, Mariuzza RA, McCormick JK, Sundberg EJ. 2007. A novel loop domain in superantigens extends their T cell receptor recognition site. J. Mol. Biol. 371:210-221. http://dx.doi.org/10.1016/j.jmb.2007.05.038.
10. Varshney AK, Mediavilla JR, Robiou N, Guh A, Wang X, Gialanella P, Levi MH, Kreiswirth BN, Fries BC. 2009. Diverse enterotoxin gene profiles among clonal complexes of Staphylococcus aureus isolates from the Bronx, New York. Appl. Environ. Microbiol. 75:6839-6849. http://dx.doi.org/10.1128/AEM.00272-09.
11. Xie Y, He Y, Gehring A, Hu Y, Li Q, Tu SI, Shi X. 2011. Genotypes and toxin gene profiles of Staphylococcus aureus clinical isolates from China. PLoS One 6:e28276. http://dx.doi.org/10.1371/journal.pone.0028276.
12. Djahmi N, Messad N, Nedjai S, Moussaoui A, Mazouz D, Richard JL, Sotto A, Lavigne JP. 2013. Molecular epidemiology of Staphylococcus aureus strains isolated from inpatients with infected diabetic foot ulcers in an Algerian University Hospital. Clin. Microbiol. Infect. 19:E398-E404. http://dx.doi.org/ 10.1111/1469-0691.12199.
13. Machuca MA, Sosa LM, Gonzalez CI. 2013. Molecular typing and virulence characteristic of methicillin-resistant Staphylococcus aureus isolates from pediatric patients in Bucaramanga, Colombia. PLoS One 8:e73434. http://dx.doi.org/10.1371/journal.pone.0073434.
14. Indrawattana N, Sungkhachat O, Sookrung N, Chongsa-nguan M, Tungtrongchitr A, Voravuthikunchai SP, Kong-ngoen T, Kurazono H, Chaicumpa W. 2013. Staphylococcus aureus clinical isolates: antibiotic susceptibility, molecular characteristics, and ability to form biofilm. BioMed Res. Int. 2013:314654. http://dx.doi.org/10.1155/2013/314654.
15. Shukla SK, Karow ME, Brady JM, Stemper ME, Kislow J, Moore N, Wroblewski K, Chyou PH, Warshauer DM, Reed KD, Lynfield R, Schwan WR. 2010. Virulence genes and genotypic associations in nasal carriage, community-associated methicillin-susceptible and methicillinresistant USA400 Staphylococcus aureus isolates. J. Clin. Microbiol. 48: 3582-3592. http://dx.doi.org/10.1128/JCM. 00657-10.
16. Wu D, Li X, Yang Y, Zheng Y, Wang C, Deng L, Liu L, Li C, Shang Y, Zhao C, Yu S, Shen X. 2011. Superantigen gene profiles and presence of exfoliative toxin genes in community-acquired meticillin-resistant Staphylococcus aureus isolated from Chinese children. J. Med. Microbiol. 60: 35-45. http://dx.doi.org/10.1099/jmm.0.023465-0.
17. Alexandrov A, Dutta K, Pascal SM. 2001. MBP fusion protein with a viral protease cleavage site: one-step cleavage/purification of insoluble proteins. Biotechniques 30:1198-1204.
18. Cook E, Wang X, Robiou N, Fries BC. 2007. Measurement of staphylococcal enterotoxin B in serum and culture supernatant with a capture enzyme-linked immunosorbent assay. Clin. Vaccine Immunol. 14:1094-1101. http://dx.doi.org/10. 1128/CVI.00183-07. (Pubitemid 47518075)
19. Kuklin NA, Pancari GD, Tobery TW, Cope L, Jackson J, Gill C, Overbye K, Francis KP, Yu J, Montgomery D, Anderson AS, McClements W, Jansen KU. 2003. Real-time monitoring of bacterial infection in vivo: development of bioluminescent staphylococcal foreign-body and deep-thigh-wound mouse infection models. Antimicrob. Agents Chemother. 47:2740-2748. http://dx.doi.org/10.1128/ AAC.47.9.2740-2748.2003. (Pubitemid 37040242)
20. Nimmo GR. 2012. USA300 abroad: global spread of a virulent strain of community-associated methicillin-resistant Staphylococcus aureus. Clin. Microbiol. Infect. 18:725-734. http://dx.doi.org/10.1111/j.1469-0691.2012.03822. x.
21. Thurlow LR, Joshi GS, Richardson AR. 2012. Virulence strategies of the dominant USA300 lineage of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA). FEMS Immunol. Med. Microbiol. 65:5-22. http://dx.doi.org/10.1111/j.1574-695X.2012.00937.x.
22. Varshney AK, Wang X, MacIntyre J, Zollner RS, Kelleher K, Kovalenko OV, Pechuan X, Byrne FR, Fries BC. 5 May 2014. Humanized staphylococcal enterotoxin B (SEB)-specific monoclonal antibodies protect from SEB intoxication and Staphylococcus aureus infections alone or as adjunctive therapy with vancomycin. J. Infect. Dis. http://dx.doi.org/10.1093/infdis/jiu198.
23. Lee PK, Kreiswirth BN, Deringer JR, Projan SJ, Eisner W, Smith BL, Carlson E, Novick RP, Schlievert PM. 1992. Nucleotide sequences and biologic properties of toxic shock syndrome toxin 1 from ovine-and bovine-associated Staphylococcus aureus. J. Infect. Dis. 165:1056-1063. http://dx.doi.org/10.1093/ infdis/165.6.1056.
24. Kohler PL, Greenwood SD, Nookala S, Kotb M, Kranz DM, Schlievert PM. 2012. Staphylococcus aureus isolates encode variant staphylococcal enterotoxin B proteins that are diverse in superantigenicity and lethality. PLoS One 7:e41157. http://dx.doi.org/10.1371/journal.pone.0041157.
25. Turner TN, Smith CL, Bohach GA. 1992. Residues 20, 22, and 26 determine the subtype specificities of staphylococcal enterotoxins C1 and C2. Infect. Immun. 60:694-697.
26. Novick RP. 2003. Mobile genetic elements and bacterial toxinoses: the superantigen-encoding pathogenicity islands of Staphylococcus aureus. Plasmid 49:93-105. http://dx.doi.org/10.1016/S0147-619X(02)00157-9. (Pubitemid 36506566)
27. Kusch K, Hanke K, Holtfreter S, Schmudde M, Kohler C, Erck C, Wehland J, Hecker M, Ohlsen K, Broker B, Engelmann S. 2011. The influence of SaeRS and sigma(B) on the expression of superantigens in different Staphylococcus aureus isolates. Int. J. Med. Microbiol. 301:488-499. http://dx.doi.org/10.1016/j.ijmm. 2011.01.003.
28. Diep BA, Carleton HA, Chang RF, Sensabaugh GF, Perdreau-Remington F. 2006. Roles of 34 virulence genes in the evolution of hospital-and community-associated strains of methicillin-resistant Staphylococcus aureus. J. Infect. Dis. 193:1495-1503. http://dx.doi.org/10.1086/503777. (Pubitemid 43794577)
29. Pragman AA, Schlievert PM. 2004. Virulence regulation in Staphylococcus aureus: the need for in vivo analysis of virulence factor regulation. FEMS Immunol. Med. Microbiol. 42:147-154. http://dx.doi.org/10.1016/j.femsim.2004.05. 005. (Pubitemid 39208541)
30. Yarwood JM, McCormick JK, Schlievert PM. 2001. Identification of a novel two-component regulatory system that acts in global regulation of virulence factors of Staphylococcus aureus. J. Bacteriol. 183:1113-1123. http://dx.doi.org/10.1128/JB.183.4.1113-1123.2001. (Pubitemid 32107706)
31. Yarwood JM, Schlievert PM. 2000. Oxygen and carbon dioxide regulation of toxic shock syndrome toxin 1 production by Staphylococcus aureus MN8. J. Clin. Microbiol. 38:1797-1803. (Pubitemid 30253918)
32. Yarwood JM, Schlievert PM. 2003. Quorum sensing in Staphylococcus infections. J. Clin. Invest. 112:1620-1625. http://dx.doi.org/10.1172/JCI20442. (Pubitemid 38063717)
33. Moran GJ, Krishnadasan A, Gorwitz RJ, Fosheim GE, McDougal LK, Carey RB, Talan DA, Group EMINS. 2006. Methicillin-resistant S. aureus infections among patients in the emergency department. N. Engl. J. Med. 355:666-674. http://dx.doi.org/10.1056/NEJMoa055356.
34. Laupland KB. 2013. Incidence of bloodstream infection: a review of population-based studies. Clin. Microbiol. Infect. 19:492-500. http://dx.doi.org/10.1111/1469-0691.12144.
35. Sowash MG, Uhlemann AC. 2014. Community-associated methicillinresistant Staphylococcus aureus case studies. Methods Mol. Biol. 1085:25-69. http://dx.doi.org/10.1007/978-1-62703-664-1-2.
36. Uhlemann AC, Otto M, Lowy FD, Deleo FR. 3 May 2013. Evolution of community-and healthcare-associated methicillin-resistant Staphylococcus aureus. Infect. Genet. Evol. http://dx.doi.org/10.1016/j.meegid.2013.04.030.
37. Ippolito G, Leone S, Lauria FN, Nicastri E, Wenzel RP. 2010. Methicillin-resistant Staphylococcus aureus: the superbug. Int. J. Infect. Dis. 14(Suppl 4):S7-S11. http://dx.doi.org/10.1016/j.ijid.2010.05.003.
38. Low DE. 2013. Toxic shock syndrome: major advances in pathogenesis, but not treatment. Crit. Care Clin. 29:651-675. http://dx.doi.org/10.1016/j.ccc. 2013.03.012.
39. Karauzum H, Chen G, Abaandou L, Mahmoudieh M, Boroun AR, Shulenin S, Devi VS, Stavale E, Warfield KL, Zeitlin L, Roy CJ, Sidhu SS, Aman MJ. 2012. Synthetic human monoclonal antibodies toward staphylococcal enterotoxin B (SEB) protective against toxic shock syndrome. J. Biol. Chem. 287:25203-25215. http://dx.doi.org/10.1074/jbc.M112.364075.
40. Larkin EA, Stiles BG, Ulrich RG. 2010. Inhibition of toxic shock by human monoclonal antibodies against staphylococcal enterotoxin B. PLoS One 5:e13253. http://dx.doi.org/10.1371/journal.pone.0013253.
41. Varshney AK, Wang X, Cook E, Dutta K, Scharff MD, Goger MJ, Fries BC. 2011. Generation, characterization, and epitope mapping of neutralizing and protective monoclonal antibodies against staphylococcal enterotoxin B-induced lethal shock. J. Biol. Chem. 286:9737-9747. http://dx.doi.org/10.1074/jbc.M110. 212407.
42. Tilahun ME, Kwan A, Natarajan K, Quinn M, Tilahun AY, Xie C, Margulies DH, Osborne BA, Goldsby RA, Rajagopalan G. 2011. Chimeric anti-staphylococcal enterotoxin B antibodies and lovastatin act synergistically to provide in vivo protection against lethal doses of SEB. PLoS One 6:e27203. http://dx.doi.org/10. 1371/journal.pone.0027203.
43. Tilahun ME, Rajagopalan G, Shah-Mahoney N, Lawlor RG, Tilahun AY, Xie C, Natarajan K, Margulies DH, Ratner DI, Osborne BA, Goldsby RA. 2010. Potent neutralization of staphylococcal enterotoxin B by synergistic action of chimeric antibodies. Infect. Immun. 78:2801-2811. http://dx.doi.org/10.1128/IAI.01121- 09.
44. Varshney AK, Wang X, Scharff MD, MacIntyre J, Zollner RS, Kovalenko OV, Martinez LR, Byrne FR, Fries BC. 2013. Staphylococcal enterotoxin B-specific monoclonal antibody 20B1 successfully treats diverse Staphylococcus aureus infections. J. Infect. Dis. 208:2058-2066. http://dx.doi.org/10.1093/infdis/ jit421.
45. Fox JL. 2013. Anthrax drug first antibacterial mAb to win approval. Nat. Biotechnol. 31:8. http://dx.doi.org/10.1038/nbt0113-8.
46. Storch GA. 1998. Humanized monoclonal antibody for prevention of respiratory syncytial virus infection. Pediatrics 102:648-651. http://dx.doi.org/10.1542/peds.102.3.648. (Pubitemid 28409269)